Health and Fitness NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response by Gary Kopycinski on November 28, 2014 Gary Kopycinski Author More in Health and Fitness: On Hantavirus, Park Forest Officials Urge Caution May 18, 2026 Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026 Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026 Results from NIH Phase 1 clinical trial support accelerated development of candidate vaccine